Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Angiotech's New Partnering Model for the Convergence Era

This article was originally published in Start Up

Executive Summary

Angiotech Pharmaceuticals, a company that has grabbed the new paradigm of convergence by both horns, has amassed intellectual property on drugs and acquired a broad array of biomaterials. Now, to access innovative medical devices, it has embarked upon a new partnering model, and the agreement that it just signed with CABG Medical is only the first example of its new style of dealmaking.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

MT037355

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel